Transcription of THE 340B DRUG DISCOUNT PROGRAM - ncpanet.org
{{id}} {{{paragraph}}}
THE 340B drug DISCOUNT PROGRAMWINTER 2013A Review and Analysis of the 340B ProgramiiA publication of the following organizations: the Biotechnology Industry Organization (BIO), the Community Oncology Alliance (COA), the National Community Pharmacists Association (NCPA), National Patient Advocate Foundation (NPAF), the Pharmaceutical Care Management Association (PCMA) and the Pharmaceutical Research and Manufacturers of America (PhRMA). Avalere Health performed supporting research and data analysis and compiled views expressed herein are those of the sponsoring 2013iiiExecutive Summary.
drug costs for uninsured indigent patients. ... manufacturers to provide discounts on outpatient prescription drugs to entities that serve high numbers of ... These figures raise critical questions about the growth of the 340B program, how the program has evolved, and
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}
LEEMORE S. DAFNY, When Discounts Raise Costs, Raising capital: an international comparison, Costs, Discounts Costs, Raise, EVALUATING BUNDLED DISCOUNTS, Discounts raise, Competition in Posted Prices With Stochastic Discounts, Discounts, Of corporate liquidity: Acquisition discounts, Of corporate liquidity: Acquisition discounts for, Cattle: Base Prices and Premiums, AAA Full-Time Benefits Summary 2010, THE DEDUCTION OF FINANCING EXPENSES